Knome to sequence 20 genomes this year

Knome, the brainchild of renowned Harvard geneticist George Church, is reportedly on track to sequence the genomes of 20 people this year. Knome garnered worldwide attention for its plans to offer full sequencing information on individuals at a price of $350,000. A slate of start-ups including 23andMe and Navigenics have popped up to offer much more limited genetic analysis to consumers interested in finding out more about the risks they face for certain diseases.

"People assume it's hypochondriacs coming to us," Knome CEO Jorge Conde tells the Boston Globe. "It isn't. It's people who are technophiles and inherently curious about themselves, and about science."

- read the article from the Boston Globe

Suggested Articles

Denali is partnering with Biogen on its Parkinson's disease program, netting a $560 million upfront fee and a $465 million investment.

In the first half of 2020, the regenerative medicine sector raised $10.7 billion, more than the total it raised in 2019.

The trial linked RG6346 to reductions in hepatitis B surface antigen that suggest the RNAi therapy can hold its own against drugs from J&J and Vir.